FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322774907> ?p ?o ?g. }

• W4322774907 endingPage "15" @default.
• W4322774907 startingPage "P5" @default.
• W4322774907 abstract "Abstract Background: Integrative therapies are shown to support cancer patients’ treatment plans, help with side effect management, and improve patients’ quality of life ([1-9]). In 2017, the American Society of Clinical Oncology endorsed the Association of Integrative Oncology’s Clinical Practice Guidelines highlighting their importance in breast cancer care. Recent studies suggest that more evidence is needed to bring attention to the role of integrative therapies in advanced breast cancer care [4, 7, 8, 10]. This analysis explores participants’ experiences with a wellness program implemented by Unite for HER (UFH), a non-profit organization that delivers integrative therapies and support services such as whole food nutrition services, medical acupuncture, oncology massage therapy, counseling, reiki, meditation, yoga, and fitness classes to patients with breast, metastatic breast, and ovarian cancer. As of April 2022, there were over 1,700 women diagnosed with metastatic breast cancer (MBC) participating in UFH locally and nationally. Methods: UFH members completed a survey about the impact of the UFH Wellness Program on the overall quality of life, including measures on side-effect management, OTC/prescription drug utilization rate, stress reduction, changes to wellness habits, and the social and emotional challenges associated with living with MBC. In total, 119 unique UFH members with MBC answered online surveys distributed by email in 2020 and 2021. Survey questions were designed to evaluate the impact of the UFH Wellness Program. Descriptive analyses of survey questions and open-ended comments were conducted to assess program impact. Results: All respondents were MBC patients/survivors. No other demographic information was collected. While 2020 respondents received mostly in-person services for part of their program, all 2021 respondents received primarily virtual services due to the Covid-19 restrictions. Despite the inaccessibility of in-person services, the satisfaction levels with the wellness program did not drop significantly in 2021. More than two-thirds of respondents (80% in 2020, 67% in 2021) indicated that the therapies offered through UFH Wellness Program significantly improved the side effects of their treatment for MBC. Notably, more than a quarter of respondents (28% in 2020, 26% in 2021) specified that due to UFH integrative therapies they were able to reduce or eliminate one or more OTC/prescription drugs to manage side effects. At the same time, the majority reported experiencing reduced levels of stress after utilizing integrative therapies offered by UFH (93% in 2020, 81% in 2021), as well as improvements in their emotional wellbeing (95% in 2020, 83% in 2021), and quality of life during or after treatment for MBC (97% in 2020, 96% in 2021). Also, 86% of respondents in both years indicated that UFH services, such as nutrition counseling, cooking classes, and exercise classes, helped them adopt and maintain healthier habits in their life. Furthermore, a qualitative analysis of open-ended comments found that 1) respondents expressed deep gratitude and appreciation for UFH integrative therapies, 2) noted that they would otherwise not be able to access such therapies due to financial barriers, and 3) helped them feel better prepared to cope with the psychosocial aspects of their MBC experience. Discussion: These results suggest that integrative therapies such as those offered by UFH can play a significant role in improving patients’ outcomes by reducing stress and drug utilization to manage side effects and improving patients’ well-being and quality of life during metastatic breast cancer treatment. These findings highlight the importance of choosing integrative oncology programs to support MBC patients’ needs in managing the psychosocial and physical side effects of the disease. This project was supported by a grant from individual donors in 2020 and 2021. References Citation Format: Elif Andac-Jones, Maria B. Gonzalo, Gail Kelly, Susan Weldon. Impact of Integrative Therapies on Patients with Metastatic Breast Cancer [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl):Abstract nr P5-07-15." @default.
• W4322774907 created "2023-03-03" @default.
• W4322774907 creator A5003513304 @default.
• W4322774907 creator A5074981697 @default.
• W4322774907 creator A5079029306 @default.
• W4322774907 creator A5087646612 @default.
• W4322774907 date "2023-03-01" @default.
• W4322774907 modified "2023-10-16" @default.
• W4322774907 title "Abstract P5-07-15: Impact of Integrative Therapies on Patients with Metastatic Breast Cancer" @default.
• W4322774907 doi "https://doi.org/10.1158/1538-7445.sabcs22-p5-07-15" @default.
• W4322774907 hasPublicationYear "2023" @default.
• W4322774907 type Work @default.
• W4322774907 citedByCount "0" @default.
• W4322774907 crossrefType "journal-article" @default.
• W4322774907 hasAuthorship W4322774907A5003513304 @default.
• W4322774907 hasAuthorship W4322774907A5074981697 @default.
• W4322774907 hasAuthorship W4322774907A5079029306 @default.
• W4322774907 hasAuthorship W4322774907A5087646612 @default.
• W4322774907 hasConcept C121608353 @default.
• W4322774907 hasConcept C126322002 @default.
• W4322774907 hasConcept C142724271 @default.
• W4322774907 hasConcept C143998085 @default.
• W4322774907 hasConcept C159110408 @default.
• W4322774907 hasConcept C175259745 @default.
• W4322774907 hasConcept C1862650 @default.
• W4322774907 hasConcept C204787440 @default.
• W4322774907 hasConcept C2775930923 @default.
• W4322774907 hasConcept C2778587949 @default.
• W4322774907 hasConcept C2779951463 @default.
• W4322774907 hasConcept C512399662 @default.
• W4322774907 hasConcept C530470458 @default.
• W4322774907 hasConcept C56837625 @default.
• W4322774907 hasConcept C71924100 @default.
• W4322774907 hasConceptScore W4322774907C121608353 @default.
• W4322774907 hasConceptScore W4322774907C126322002 @default.
• W4322774907 hasConceptScore W4322774907C142724271 @default.
• W4322774907 hasConceptScore W4322774907C143998085 @default.
• W4322774907 hasConceptScore W4322774907C159110408 @default.
• W4322774907 hasConceptScore W4322774907C175259745 @default.
• W4322774907 hasConceptScore W4322774907C1862650 @default.
• W4322774907 hasConceptScore W4322774907C204787440 @default.
• W4322774907 hasConceptScore W4322774907C2775930923 @default.
• W4322774907 hasConceptScore W4322774907C2778587949 @default.
• W4322774907 hasConceptScore W4322774907C2779951463 @default.
• W4322774907 hasConceptScore W4322774907C512399662 @default.
• W4322774907 hasConceptScore W4322774907C530470458 @default.
• W4322774907 hasConceptScore W4322774907C56837625 @default.
• W4322774907 hasConceptScore W4322774907C71924100 @default.
• W4322774907 hasIssue "5_Supplement" @default.
• W4322774907 hasLocation W43227749071 @default.
• W4322774907 hasOpenAccess W4322774907 @default.
• W4322774907 hasPrimaryLocation W43227749071 @default.
• W4322774907 hasRelatedWork W2028340468 @default.
• W4322774907 hasRelatedWork W2062524166 @default.
• W4322774907 hasRelatedWork W2067295102 @default.
• W4322774907 hasRelatedWork W2107329718 @default.
• W4322774907 hasRelatedWork W2154282809 @default.
• W4322774907 hasRelatedWork W2384844841 @default.
• W4322774907 hasRelatedWork W2484228082 @default.
• W4322774907 hasRelatedWork W4302016068 @default.
• W4322774907 hasRelatedWork W4327851461 @default.
• W4322774907 hasRelatedWork W4379114634 @default.
• W4322774907 hasVolume "83" @default.
• W4322774907 isParatext "false" @default.
• W4322774907 isRetracted "false" @default.
• W4322774907 workType "article" @default.